Today: 19 May 2026
Browse Category

NASDAQ:KYIV 16 October 2025 - 6 January 2026

Kyivstar Group Ltd Stock (NASDAQ: KYIV): News, Price Forecasts, and Analyst Outlook for December 22, 2025

Kyivstar Group Ltd Stock (NASDAQ: KYIV): News, Price Forecasts, and Analyst Outlook for December 22, 2025

Kyivstar shares closed at $13.14 on December 22, down 3.4% after a volatile week that saw the stock drop from around $15. The company announced it acquired SUNVIN 11 LLC, owner of a 12.9 MW solar plant in Ukraine, for about $8.2 million. Kyivstar said the move aims to boost energy resilience and hedge electricity costs. Trading volume reached roughly 279,000 shares.
22 December 2025
·
Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar became the first Ukrainian company to list on Nasdaq on August 15, 2025, raising $178 million and debuting near $14 per share. After dropping to $11.25 by mid-September, the stock rebounded to $14.06 on October 16 following announcements of a $1 billion network upgrade and a Mastercard partnership. Four analysts rate KYIV a “Strong Buy” with an average price target of $17.08.
16 October 2025
··

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

19 May 2026
New York, May 19, 2026, 2:04 PM EDT Recursion Pharmaceuticals shares fell in Tuesday afternoon trading after touching a fresh 52-week low, keeping pressure on one of the better-known AI drug-discovery names even as the company points to clinical progress and a cash runway into 2028. The stock was recently down about 2.2% at $2.825, after trading as low as $2.77, with volume above 10 million shares and a market value near $1.49 billion. Investing.com reported earlier Tuesday that Recursion had hit a 52-week low at $2.79 and said the shares were down about 36% over the past year. (Investing.com)
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
Go toTop